These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 32685012)
1. ZnS@ZIF-8 core-shell nanoparticles incorporated with ICG and TPZ to enable H Fang C; Cen D; Wang Y; Wu Y; Cai X; Li X; Han G Theranostics; 2020; 10(17):7671-7682. PubMed ID: 32685012 [TBL] [Abstract][Full Text] [Related]
2. Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles. Huang X; Wu J; He M; Hou X; Wang Y; Cai X; Xin H; Gao F; Chen Y Mol Pharm; 2019 May; 16(5):2172-2183. PubMed ID: 30978027 [TBL] [Abstract][Full Text] [Related]
3. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy. Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223 [TBL] [Abstract][Full Text] [Related]
4. A triple-stimulus responsive melanin-based nanoplatform with an aggregation-induced emission-active photosensitiser for imaging-guided targeted synergistic phototherapy/hypoxia-activated chemotherapy. Yu J; Zhang X; Pei Z; Shuai Q J Mater Chem B; 2021 Nov; 9(44):9142-9152. PubMed ID: 34693960 [TBL] [Abstract][Full Text] [Related]
5. Oxygen Self-Sufficient Core-Shell Metal-Organic Framework-Based Smart Nanoplatform for Enhanced Synergistic Chemotherapy and Photodynamic Therapy. Ren SZ; Wang B; Zhu XH; Zhu D; Liu M; Li SK; Yang YS; Wang ZC; Zhu HL ACS Appl Mater Interfaces; 2020 Jun; 12(22):24662-24674. PubMed ID: 32394704 [TBL] [Abstract][Full Text] [Related]
6. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies. Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of dual-stimuli responsive metal organic framework-coated iridium oxide nanocomposite functionalized with tumor targeting albumin-folate for synergistic photodynamic/photothermal cancer therapy. Deng X; Zhao R; Song Q; Zhang Y; Zhao H; Hu H; Zhang Z; Liu W; Lin W; Wang G Drug Deliv; 2022 Dec; 29(1):3142-3154. PubMed ID: 36164704 [TBL] [Abstract][Full Text] [Related]
8. Theranostic nanoparticles ZIF-8@ICG for pH/NIR-responsive drug-release and NIR-guided chemo-phototherapy against non-small-cell lung cancer. Lu K; Pan X; Zheng J; Cheng D; Zheng L; Zhang X J Mater Sci Mater Med; 2024 Jun; 35(1):32. PubMed ID: 38896160 [TBL] [Abstract][Full Text] [Related]
9. Cancer Cell-Targeted Photosensitizer and Therapeutic Protein Co-Delivery Nanoplatform Based on a Metal-Organic Framework for Enhanced Synergistic Photodynamic and Protein Therapy. Ding L; Lin X; Lin Z; Wu Y; Liu X; Liu J; Wu M; Zhang X; Zeng Y ACS Appl Mater Interfaces; 2020 Aug; 12(33):36906-36916. PubMed ID: 32706242 [TBL] [Abstract][Full Text] [Related]
11. H Qiao L; Ou Y; Li L; Wu S; Guo Y; Liu M; Yu D; Chen Q; Yuan J; Wei C; Ou C; Li H; Cheng D; Yu Z; Li Z J Nanobiotechnology; 2024 Apr; 22(1):205. PubMed ID: 38658965 [TBL] [Abstract][Full Text] [Related]
12. Engineered biomimetic nanoreactor for synergistic photodynamic-chemotherapy against hypoxic tumor. Guo H; Wang L; Wu W; Guo M; Yang L; Zhang Z; Cao L; Pu F; Huang X; Shao Z J Control Release; 2022 Nov; 351():151-163. PubMed ID: 36122895 [TBL] [Abstract][Full Text] [Related]
13. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy. Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718 [TBL] [Abstract][Full Text] [Related]
14. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy. Dai Y; Wang B; Sun Z; Cheng J; Zhao H; Wu K; Sun P; Shen Q; Li M; Fan Q ACS Appl Mater Interfaces; 2019 Oct; 11(43):39410-39423. PubMed ID: 31578854 [TBL] [Abstract][Full Text] [Related]
15. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy. Dong Y; Zhou L; Shen Z; Ma Q; Zhao Y; Sun Y; Cao J Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784 [TBL] [Abstract][Full Text] [Related]
16. Near-infrared photoactivatable three-in-one nanoagents to aggravate hypoxia and enable amplified photo-chemotherapy. Yu N; Zhou J; Xu H; Wang F; Wang X; Tang L; Li J; Wang X; Lu X Biomater Adv; 2024 Oct; 163():213962. PubMed ID: 39032435 [TBL] [Abstract][Full Text] [Related]
17. Rational design of non-toxic GOx-based biocatalytic nanoreactor for multimodal synergistic therapy and tumor metastasis suppression. Hang L; Zhang T; Wen H; Li M; Liang L; Tang X; Zhou C; Tian J; Ma X; Jiang G Theranostics; 2021; 11(20):10001-10011. PubMed ID: 34815800 [No Abstract] [Full Text] [Related]
18. GSH-Responsive and Hypoxia-Activated Multifunctional Nanoparticles for Synergetically Enhanced Tumor Therapy. Liu C; Jia S; Tu L; Yang P; Wang Y; Ke S; Shi W; Ye S ACS Biomater Sci Eng; 2022 May; 8(5):1942-1955. PubMed ID: 35357802 [TBL] [Abstract][Full Text] [Related]
19. Synergy of Tumor Microenvironment Remodeling and Autophagy Inhibition to Sensitize Radiation for Bladder Cancer Treatment. Lin T; Zhang Q; Yuan A; Wang B; Zhang F; Ding Y; Cao W; Chen W; Guo H Theranostics; 2020; 10(17):7683-7696. PubMed ID: 32685013 [TBL] [Abstract][Full Text] [Related]
20. Self-accelerating H Tang Y; Ji Y; Yi C; Cheng D; Wang B; Fu Y; Xu Y; Qian X; Choonara YE; Pillay V; Zhu W; Liu Y; Nie Z Theranostics; 2020; 10(19):8691-8704. PubMed ID: 32754272 [No Abstract] [Full Text] [Related] [Next] [New Search]